| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |